Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William T Barry

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|October 27, 2009
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivoMichael A Morse, Junping Wei, Zachary Hartman, et al.
Scientific Reports|March 12, 2020
MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcomaChristopher E Lietz, Cassandra Garbutt, William T Barry, et al.
Journal of Clinical Pharmacology|December 6, 2019
Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)Manish R Sharma, Shailly Mehrotra, Elizabeth Gray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2018
Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)Mark Jesus M Magbanua, Hope S Rugo, Denise M Wolf, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response BiomarkersJanet K Horton, Rachel C Blitzblau, Sua Yoo, et al.
The Oncologist|October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physiciansJeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
The Oncologist|May 12, 2021
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 12, 2013
Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapyLee W Jones, Diane R Fels, Miranda West, et al.
International Journal of Cancer|November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancerAndrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|October 27, 2009
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivoMichael A Morse, Junping Wei, Zachary Hartman, et al.
Scientific Reports|March 12, 2020
MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcomaChristopher E Lietz, Cassandra Garbutt, William T Barry, et al.
Journal of Clinical Pharmacology|December 6, 2019
Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)Manish R Sharma, Shailly Mehrotra, Elizabeth Gray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2018
Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)Mark Jesus M Magbanua, Hope S Rugo, Denise M Wolf, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response BiomarkersJanet K Horton, Rachel C Blitzblau, Sua Yoo, et al.
The Oncologist|October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physiciansJeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
The Oncologist|May 12, 2021
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 12, 2013
Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapyLee W Jones, Diane R Fels, Miranda West, et al.
International Journal of Cancer|November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancerAndrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.
Pageof 13